1.Patientswithbleedingorbleedingtendency(especiallyduetolackofcertaincoagulationfactors).2.Patientswithsystemicallergycausedbydheparinsodium.3.Thrombocytopeniaandpositiveplateletaggregationinducedbyhe
1.Itcanbeusedfordeepveinthrombosis(DVT)andpreventionofpulmonaryembolism(PE)anddisseminatedintravascularcoagulation(DIC)inpatientswithgeneralsurgery,totalhiporkneereplacement,long-termbedrestormalignan
Dheparinsodiumcouldnotbeabsorbedbyoraladministration,butbecameeffective3minafterintravenousinjection,withamaximumeffecttimeof2~4handahalf-lifeofabout2h.Theeffectwaseffective2~4haftersubcutaneousinject
Muchmorethanordinaryheparin.InclinicalapplicationsshowitsantiⅩaactivityisstronganddurable,andtheeffectofprolongAPTTfaint.Therefore,itshowsstrongantithromboticeffectandlowriskofbleeding.Inaddition,dhe